Sk Biopharmaceuticals Co., Ltd. (326030)
Market Closed
15 Jun, 06:30
KRX SM KRX SM Primary ₩
90,200. 00
+2,300
+2.6166%
₩
10.95T Market Cap
- P/E Ratio
- Div Yield
113,735 Volume
566.84 Eps
₩ 87,900
Previous Close Want to track 326030 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sk Biopharmaceuticals Co., Ltd. (326030) Statistics
Valuation metrics
Market Cap 10.95T
Enterprise value 6.62T
Trailing P/E (ttm) 19.28
Forward P/E -
PEG ratio 0.57
Price/Sales (ttm) 8.71
Price/Book (mrq) 7.22
Enterprise Value/Revenue 8.38
Enterprise Value/EBITDA 37.62
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 305.53K
Average volume (90 days) 473.84K
Price summary
52-Week low 81,000
52-Week high 144,100
Beta -
50-Day moving average 94,992.19
200-Day moving average 109,784.59
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.44%
Operating margin 0.34%
Operational effectiveness
Return on assets 0.26%
Return on equity 0.46%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 10,329.39
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 4,559.28
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4,063.28
Total debt (mrq) -
Total Debt/Equity (mrq) 0.05
Current ratio (mrq) 2.49%
Book value per share (mrq) 12,182.89
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
